Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Ellingson

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Nature Cell Biology|October 3, 2022
Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cellsTatyana D Larionova, Soniya Bastola, Tatiana E Aksinina, et al.
Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
AJNR. American Journal of Neuroradiology|June 26, 2024
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in AdultsBenjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, et al.
Neuro-Oncology Advances|October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastomaHao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Neuro-Oncology|December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Nature Cell Biology|October 3, 2022
Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cellsTatyana D Larionova, Soniya Bastola, Tatiana E Aksinina, et al.
Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
AJNR. American Journal of Neuroradiology|June 26, 2024
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in AdultsBenjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, et al.
Neuro-Oncology Advances|October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastomaHao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Neuro-Oncology|December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Pageof 29